🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSingapore HSA regulations — GLP-1 in the city-state

Singapore HSA regulations — GLP-1 in the city-state

wei_SG Thu, Mar 5, 2026 at 11:19 AM 8 replies 255 viewsPage 1 of 2
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Mar 5, 2026 at 12:44 PM#1

I'm trying to compile information on how different states regulate compounding pharmacies, especially for GLP-1 peptides. I've discovered that what's allowed in Texas might be completely different from what's allowed in New York, and it's incredibly confusing.

Anyone have experience navigating this patchwork? Specifically:

  • Which states have the strictest regulations?
  • Which states allow out-of-state compounding pharmacies to ship in?
  • Are there states where compounded semaglutide is effectively banned?
25 7WendyG_ATL, SaraMom3, Dr.MetabolicMD and 22 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Mar 5, 2026 at 1:01 PM#2

This is a massive topic but I'll give you the highlights from my research:

STRICTEST STATES:

  • California: Requires resident pharmacist for compounding, strict Board of Pharmacy oversight, recent crackdown on telehealth-prescribed compounded medications
  • New York: Historically strict on out-of-state shipments, requires pharmacy to be licensed in NY
  • Massachusetts: Post-NECC, arguably the tightest compounding regs in the country

MORE PERMISSIVE STATES:

  • Texas: Large compounding pharmacy industry, generally business-friendly regulatory environment
  • Florida: Home to many 503B outsourcing facilities, relatively permissive
  • Utah: Has carved out specific provisions for compounding

CROSS-STATE SHIPPING:

503B outsourcing facilities (federally registered) can generally ship across state lines. 503A pharmacies typically need to be licensed in the receiving state, though enforcement varies.

35 11MikeNYC_runner and 32 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Mar 5, 2026 at 1:18 PM#3

Adding to what was shared above's excellent summary — the key legal concept is that 503A pharmacies are regulated by STATE boards, while 503B facilities are regulated by FDA at the federal level. This creates a two-tier system where a 503A in Florida might be able to do things a 503A in California can't.

For consumers, the practical question is usually: "Can Pharmacy X in State Y ship to me in State Z?" The answer depends on whether the pharmacy is licensed in your state. Most of the big compounding pharmacies hold licenses in multiple states for this reason.

11 14adam_van, Dr.SurgeonPGH, rachel_ABQ and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Mar 5, 2026 at 1:35 PM#4

As someone in Texas, I can tell you the compounding pharmacy scene here is huge. Empower Pharmacy, one of the largest 503B facilities in the country, is based in Houston. Many telehealth companies source from TX-based compounders.

That said, Texas isn't the Wild West — the Texas State Board of Pharmacy does conduct inspections and has taken enforcement action. They shut down two compounders last year for violations.

25 14JenPlateau, SallyK_inj, CryptoCarl and 22 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Mar 5, 2026 at 1:52 PM#5

California checking in. It's definitely harder here. My doctor prescribed compounded sema and my local pharmacy couldn't fill it — they said their license doesn't allow them to compound this particular formulation. I ended up getting it from a 503B facility in another state that's licensed in CA.

The extra hoops are annoying but I also appreciate that CA is trying to protect patients. It's a balancing act. 🤷‍♀️

22 16Dr.PulmRoch, maya_sedona, stefan_berlin and 19 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register